Clinical Trials Directory

Trials / Sponsors / HiberCell, Inc.

HiberCell, Inc.

Industry · 16 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
Renal Cell Carcinoma
Phase 12024-04-29
TerminatedA Maintenance Therapy Study of Odetiglucan With CDX-1140 in Patients With Metastatic Pancreatic Ductal Adenoca
Metastatic Pancreatic Adenocarcinoma
Phase 12022-12-15
TerminatedA Study of HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)
Squamous Cell Carcinoma of Head and Neck, Colo-rectal Cancer, Non Small Cell Lung Cancer
Phase 12022-02-23
CompletedPhase 2 Study of Imprime PGG and Pembrolizumab in Patients With HR+/HER2- Metastatic Breast Cancer (mBCA)
Malignant Neoplasm of Breast
Phase 22021-11-09
WithdrawnStudy of Neoadjuvant Imprime PGG and Pembrolizumab for Stage III, Resectable Melanoma
Pathologic Stage III Cutaneous Melanoma AJCC v8
Phase 22021-08-15
CompletedA Study of HC-5404-FU to Establish the Maximum Tolerated Dose (MTD)
Renal Cell Carcinoma, Gastric Cancer, Metastatic Breast Cancer
Phase 12021-06-08
TerminatedPhase 2 Study of Imprime PGG & Pembrolizumab in Subjects With Adv SCCHN Who Failed Pembro Monotherapy or Exper
Squamous Cell Carcinoma of the Head and Neck
Phase 22017-11-08
CompletedStudy of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast Cancer
Advanced Melanoma, Triple-Negative Breast Cancer
Phase 22017-02-22
TerminatedStudy of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type C
Colorectal Cancer
Phase 32011-04-01
CompletedEfficacy/Safety of Imprime PGG With Cetuximab & Paclitaxel/Carboplatin Therapy in Pts With Untreated Advanced
NSCLC
Phase 22009-08-01
CompletedEfficacy and Safety Study of Imprime PGG With Cetuximab in Subjects With Stage IV KRAS-Mutated Colorectal Canc
Colorectal Cancer
—2009-06-01
CompletedEfficacy/Safety of Imprime PGG® Injection With Bevacizumab and Paclitaxel/Carboplatin in Patients With Untreat
Non-Small Cell Lung Cancer
Phase 22009-06-01
CompletedSafety/Efficacy Study of Imprime PGG With Cetuximab in Patients With Recurrent/Progressive Colorectal Carcinom
Recurrent Colorectal Carcinoma, Progressive Colorectal Carcinoma
Phase 1 / Phase 22007-10-01
CompletedPhase I/II, Randomized, Double-Blind, Study of the Progenitor Cell Mobilizing Effects of Imprime PGG™ Injectio
Healthy
Phase 1 / Phase 22006-11-01
CompletedMultiple-Dose, Dose-Escalation Safety, Pharmacodynamics, and Pharmacokinetics Study of Imprime PGG™ Injection
Healthy
Phase 12006-05-01
CompletedPhase Ia Dose-Escalation Safety, Pharmacodynamic and Pharmacokinetic Study of Imprime PGG™ Injection
Healthy
Phase 12005-12-01